Insights

Strategic Funding Leverage ARPA-H funding collaboration with GE HealthCare and the FLASH program to position DNA Script as a key partner for scalable cell-free DNA production and distributed DNA manufacturing capabilities, targeting large healthcare and biopharma clients seeking rapid on-demand DNA synthesis.

Global Distribution capitalize on recent distribution agreements across India, Latin America, Japan, and South Korea to introduce SYNTAX platform to new regional markets; tailor regional partnerships and localized support to accelerate sales cycles and expand installed bases.

Enzymatic Edge Highlight enzymatic DNA synthesis as a differentiator for customers needing rapid, on-demand DNA with reduced supply chain complexity; position the SYNTAX benchtop printer for labs pursuing in-house oligo production and accelerated R&D timelines.

Strategic Partnerships Target collaborations with pharma and CROs for vaccine and therapeutic development, leveraging DNA Script, Quantoom, Eva Pharma, and Gencell networks to co-develop integrated platforms and joint go-to-market strategies in emerging markets.

Growth Momentum Capitalize on leadership changes and strong funding runway to present DNA Script as a rapidly expanding innovator; align sales campaigns with ongoing expansions, upcoming deployments, and multi-year programs to secure enterprise-level deals with life sciences organizations.

Similar companies to DNA Script

DNA Script Tech Stack

DNA Script uses 8 technology products and services including IBM Cognos Analytics, iCIMS, GitHub, and more. Explore DNA Script's tech stack below.

Media & News

DNA Script's Email Address Formats

DNA Script uses at least 8 email formats:
DNA Script Email FormatsExamplePercentage
First.Last@dnascript.coJohn.Doe@dnascript.co
81%
FL@dnascript.coJD@dnascript.co
14%
FLast@dnascript.coJDoe@dnascript.co
4%
Last@dnascript.coDoe@dnascript.co
1%
FLast@dnascript.comJDoe@dnascript.com
50%
First.Last@dnascript.comJohn.Doe@dnascript.com
39%
Last@dnascript.comDoe@dnascript.com
5%
LF@dnascript.comDJ@dnascript.com
6%

Frequently Asked Questions

What is DNA Script's official website and social media links?

Minus sign iconPlus sign icon
DNA Script's official website is dnascript.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does DNA Script generate?

Minus sign iconPlus sign icon
As of October 2026, DNA Script's annual revenue is estimated to be $1M - $10M.

What is DNA Script's SIC code and NAICS code?

Minus sign iconPlus sign icon
DNA Script's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does DNA Script have currently?

Minus sign iconPlus sign icon
As of October 2026, DNA Script has approximately 130 employees across 4 continents, including Europe, North America and Africa. Key team members include Chief Financial Officer: S. P., Vice President Of Sales: J. S. and Vp Of Ip: D. C. Explore DNA Script's employee directory with LeadIQ.

What industry does DNA Script belong to?

Minus sign iconPlus sign icon
DNA Script operates in the Biotechnology Research industry.

What technology does DNA Script use?

Minus sign iconPlus sign icon
DNA Script's tech stack includes IBM Cognos Analytics, iCIMS, GitHub, InVision, Docker, Microsoft 365, ZoomInfo and Cisco.

What is DNA Script's email format?

Minus sign iconPlus sign icon
DNA Script's email format typically follows the pattern of First.Last@dnascript.co. Find more DNA Script email formats with LeadIQ.

How much funding has DNA Script raised to date?

Minus sign iconPlus sign icon
As of October 2026, DNA Script has raised $320M in funding. The last funding round occurred on Feb 06, 2025.

When was DNA Script founded?

Minus sign iconPlus sign icon
DNA Script was founded in 2014.
DNA Script logo

DNA Script

Biotechnology ResearchÎle-de-France, France51-200 Employees

DNA Script is a biotechnology research company based in Île-de-france, France, focused on enzymatic DNA synthesis. Its core R&D activities include enzyme engineering, surface and nucleotide chemistries, and instrumentation development. The company markets the SYNTAX platform, a benchtop DNA printer powered by enzymatic technology, enabling on-demand DNA synthesis for genomics research. The organization is located at 67 Avenue de Fontainebleau le Kremlin-bicêtre, Île-de-france 94270 France, and employs between 51 and 200 people. In 2026, DNA Script signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and BioStream Co. to expand global access to SYNTAX. Earlier collaborations include partnerships with Quantoom Biosciences and EVA Pharma, and the company appointed Marc Montserrat as Chief Executive Officer in October 2024.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $320M

    DNA Script has raised a total of $320M of funding over 12 rounds. Their latest funding round was raised on Feb 06, 2025 as a Grant.

  • $1M - $10M

    DNA Script's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.